WuXi AppTec looks to unload its Philadelphia manufacturing sites and WuXi Biologics slows its rapid expansion in the U.S. as ...

WuXi is considering the sale of some US and European operations to mitigate the impact of upcoming restrictions.

Ahead of the BIOSECURE Act, WuXi AppTec is in talks to sell its Philadelphia-based cell and gene therapy unit, and WuXi ...

As the BIOSECURE Act works its way through the U.S. legislative branch, two companies named in the bill are reportedly ...

Drugmakers have been targeted on national security grounds and could lose customers if Congress passes Biosecure Act ...

The current status of the Biosecure Act is that it was passed ​ by the US House of Representatives on Sep 9, with a vote of ...

The Financial Times reported Thursday that WuXi AppTec is looking to sell its cell and gene therapy manufacturing unit, with facilities in Philadelphia, while WuXi Biologics wants to offload some of ...

WuXi AppTec and Wuxi Biologics have denied posing a security risk to the U.S. and associations with the People's Liberation Army in China. The bill will move onto the Senate floor before it can be ...

WUXI APPTEC (02359.HK) and WUXI BIO (02269.HK) are studying the sale of some of their operations in Europe and the US due to ...